{"database": "openregs", "table": "documents", "rows": [["FDA-2017-D-5767-0002", "FDA", "FDA-2017-D-5767", "ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin Guidance for Industry DRAFT GUIDANCE", "Other", "Guidance", "2017-10-03T04:00:00Z", 2017, 10, "2017-10-03T04:00:00Z", "2017-12-05T04:59:59Z", "2024-11-07T01:17:03Z", null, 1, 0, "0900006482b94e60"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2017-D-5767-0002"], "units": {}, "query_ms": 0.33508497290313244, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}